A 12-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of the Efficacy and Safety of Appetite Suppressant, New Formulation of Pentermine 30mg Diffuse Controlled Release in the Treatment of Korean Obese Patients
DIABETES(2009)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要